http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115109165-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a757dbe1fc01bf4d7041d696d3a8227 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-165 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y301-03001 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-85 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56983 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-17023 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-485 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-16 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-85 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00 |
| filingDate | 2021-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e5a1f58b4105cc6398e8478e464c89a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_273e6e6c9dcd24c506bbd59f53f407ef http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a638d3dbfc80d30f442893fd7d77bcd9 |
| publicationDate | 2022-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-115109165-A |
| titleOfInvention | A kind of recombinant fusion hACE2-SEAP protein and its preparation method and application |
| abstract | The present invention provides a recombinant fusion hACE2-SEAP protein, a preparation method and application thereof, wherein the recombinant fusion hACE2-SEAP protein is formed by connecting the amino acid sequences of the hACE2 protein and the SEAP protein with a connecting peptide, and the present invention also provides a Recombinant fusion hACE2-SEAP protein expression vector and preparation method and application thereof. The recombinant fusion hACE2-SEAP protein of the present invention can specifically and efficiently bind to the S1 antigen of SARS-COV-2, and is stably expressed in vitro; it avoids the free hACE2 and SEAP produced by traditional labeling, and reduces detection non-specificity; The catalytic activity of AP directly causes the substrate to emit light, omitting the labeling process of the label, avoiding the batch difference of traditional labeling; omitting the purification and preparation process of the recombinant fusion hACE2-SEAP protein, reducing the production cost; saving chemiluminescence detection method The operation steps and time of SARS-COV-2 neutralizing antibodies can be used in the preparation of coronavirus detection kits, which are suitable for large-scale clinical detection. |
| priorityDate | 2021-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 567.